Table 2b.
3-Months | 6-Months | |
---|---|---|
5% or more | ||
Overall | 17.9% (6.8, 37.6) | 50.0% (30.7, 69.3) |
Topiramate Only | 27.3% (7.3, 60.7) | 66.7% (30.9, 91.0) |
| ||
10% or more | ||
Overall | 0% | 13.6% (3.6, 36.0) |
Topiramate Only | 0% | 11.1% (0.6, 49.3) |
3-Months | 6-Months | |
---|---|---|
5% or more | ||
Overall | 17.9% (6.8, 37.6) | 50.0% (30.7, 69.3) |
Topiramate Only | 27.3% (7.3, 60.7) | 66.7% (30.9, 91.0) |
| ||
10% or more | ||
Overall | 0% | 13.6% (3.6, 36.0) |
Topiramate Only | 0% | 11.1% (0.6, 49.3) |